Friday, May 1, 2026

Alteogen Secures U.S. Patent for Keytruda Subcutaneous Injection: What This Means for ALT-B4 and Future Treatments

Alteogen secures a U.S. patent for a subcutaneous Keytruda formulation using ALT-B4, ensuring exclusivity until 2043 and potential $1B in sales.

UN Human Rights Council’s New Resolution: What It Means for North Korean Human Rights in 2026

The NHRCK supports the UN resolution on North Korean human rights, urging global action and highlighting ongoing concerns over abuses.

DeepSeek Faces Global Backlash Over Data Privacy Concerns

Concerns over DeepSeek lead to global regulatory actions, including a suspension in South Korea due to data privacy issues.

Tag: Hwang Chul Soon

No posts to display

Top News

- Our Sponsors Ad -

Follow us